Across TCGA pan-cancer cohorts, LINC02872 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC02872 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02872 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02872 expression acts as an unfavorable survival marker.

ACC and UCEC are the cancer types where LINC02872 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.188	0.820	<.001	12	view →
UCEC	OS	Median	III,IV	0.061	0.588	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC02872 tumor-vs-normal RNA expression · all LINC02872 data types